Epidemiological, demographic and histological characterization of advanced pancreatic cancer patients diagnosed by tru-cut biopsy
Abstract
Introduction: pancreatic cancer has the worst prognosis among malignant tumors with only 5 % survival after five years of diagnosed patients. The diagnosis, usually late, is carried out when the disease is advanced or when there is metastasis.
Objective: to characterize the patients with histological diagnosis of stages III and IV pancreatic cancer, in which the tru-cut biopsy was applied as a technique for taking the sample.
Method: a descriptive study was carried out on 11 patients with stages III and IV pancreatic cancer whose histological confirmation was achieved by means of the tru-cut biopsy in the General Provincial Teaching Hospital of Ciego de Ávila in the period January-December 2017. The variables studied were: age, sex, topographic location, risk factors, histology, complications and survival.
Results: the age group of 66-81 years (45,45 %), the male sex (63,64 %), the location in the head (54,55 %), and smoking (21,74 %) as a risk factor prevailed. Survival after seven months was high (90,90 %), and its highest range was 10-12 months. The complications were minimal and not serious.
Conclusions: patients diagnosed with pancreatic cancer stages III and IV were characterized according to the variables to be studied. In the course of the investigation, the survival achieved in them was shown given the onco-specific therapeutic possibilities fostered by the histological study, achieved by means of a tru-cut biopsyDownloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Antonio Ernesto Cabrera Linares, José Miguel Hernández Hernández, Francisco Hernández González, Yadier González González, Marcos Noa Arias, Marisleidy Fernández González
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
